BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 23837905)

  • 1. Single-dose radiosurgical treatment for hepatic metastases--therapeutic outcome of 138 treated lesions from a single institution.
    Habermehl D; Herfarth KK; Bermejo JL; Hof H; Rieken S; Kuhn S; Welzel T; Debus J; Combs SE
    Radiat Oncol; 2013 Jul; 8():175. PubMed ID: 23837905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stereotactic Robotic Body Radiotherapy for Patients With Unresectable Hepatic Oligorecurrence.
    Berkovic P; Gulyban A; Nguyen PV; Dechambre D; Martinive P; Jansen N; Lakosi F; Janvary L; Coucke PA
    Clin Colorectal Cancer; 2017 Dec; 16(4):349-357.e1. PubMed ID: 28462852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypofractionated image-guided breath-hold SABR (stereotactic ablative body radiotherapy) of liver metastases--clinical results.
    Boda-Heggemann J; Dinter D; Weiss C; Frauenfeld A; Siebenlist K; Attenberger U; Ottstadt M; Schneider F; Hofheinz RD; Wenz F; Lohr F
    Radiat Oncol; 2012 Jun; 7():92. PubMed ID: 22710033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SBRT-SG-01: final results of a prospective multicenter study on stereotactic body radiotherapy for liver metastases.
    Rodríguez MR; Chen-Zhao X; Hernando O; Flamarique S; Fernández-Letón P; Campo M; López M; Rodríguez M; Zucca D; Martínez D; Sánchez-Saugar E; Mañeru F; Ruiz-Zorrilla JG; de Acilu PG; Valero J; Montero A; Ciérvide R; Alvarez B; García-Aranda M; Alonso R; de la Casa MA; Alonso L; Nuñez M; Martí J; Arias F
    Clin Transl Oncol; 2024 Jul; 26(7):1790-1797. PubMed ID: 38431539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stereotactic Body Radiotherapy (SBRT) for Spinal Metastases: Who Will Benefit the Most from SBRT?
    Park HJ; Kim HJ; Won JH; Lee SC; Chang AR
    Technol Cancer Res Treat; 2015 Apr; 14(2):159-67. PubMed ID: 24502552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Curative-intent radiotherapy in patients with oligometastatic lesions from colorectal cancer: A single-center study.
    He X; Zhang P; Li Z; Bi F; Xu F; Wang X; Shen Y; Li Q; Qiu M
    Medicine (Baltimore); 2018 Oct; 97(40):e12601. PubMed ID: 30290630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypofractionated radiosurgery for intact or resected brain metastases: defining the optimal dose and fractionation.
    Eaton BR; Gebhardt B; Prabhu R; Shu HK; Curran WJ; Crocker I
    Radiat Oncol; 2013 Jun; 8():135. PubMed ID: 23759065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase I dose escalation study of helical intensity-modulated radiotherapy-based stereotactic body radiotherapy for hepatocellular carcinoma.
    Kim JW; Seong J; Lee IJ; Woo JY; Han KH
    Oncotarget; 2016 Jun; 7(26):40756-40766. PubMed ID: 27213593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Local Control Outcomes Using Stereotactic Body Radiation Therapy for Liver Metastases From Colorectal Cancer.
    Joo JH; Park JH; Kim JC; Yu CS; Lim SB; Park IJ; Kim TW; Hong YS; Kim KP; Yoon SM; Park J; Kim JH
    Int J Radiat Oncol Biol Phys; 2017 Nov; 99(4):876-883. PubMed ID: 29063852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereotactic Body Radiotherapy (SBRT) for liver metastasis - clinical outcomes from the international multi-institutional RSSearch® Patient Registry.
    Mahadevan A; Blanck O; Lanciano R; Peddada A; Sundararaman S; D'Ambrosio D; Sharma S; Perry D; Kolker J; Davis J
    Radiat Oncol; 2018 Feb; 13(1):26. PubMed ID: 29439707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereotactic body radiotherapy (SBRT) for adrenal metastases of oligometastatic or oligoprogressive tumor patients.
    König L; Häfner MF; Katayama S; Koerber SA; Tonndorf-Martini E; Bernhardt D; von Nettelbladt B; Weykamp F; Hoegen P; Klüter S; Susko MS; Debus J; Hörner-Rieber J
    Radiat Oncol; 2020 Feb; 15(1):30. PubMed ID: 32019553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Additional chemotherapy improved local control and overall survival after stereotactic body radiation therapy for patients with oligo-recurrence.
    Nakamura M; Hashimoto N; Mayahara H; Uezono H; Harada A; Nishikawa R; Matsuo Y; Kawaguchi H; Nishimura H
    Radiat Oncol; 2018 Apr; 13(1):75. PubMed ID: 29688858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiosurgery in the management of brain metastasis: a retrospective single-center study comparing Gamma Knife and LINAC treatment.
    Tuleasca C; Negretti L; Faouzi M; Magaddino V; Gevaert T; von Elm E; Levivier M
    J Neurosurg; 2018 Feb; 128(2):352-361. PubMed ID: 28338441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stereotactic Body radiation therapy for liver tumors with or without rotational intensity modulated radiation therapy.
    Nouhaud E; Créhange G; Cueff A; Quivrin M; Rouffiac-Thouant M; Mineur L; Garcia R; Chamois J; Maingon P
    BMC Res Notes; 2013 Nov; 6():492. PubMed ID: 24279802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intensity modulated radiation therapy (IMRT) for sinonasal tumors: a single center long-term clinical analysis.
    Askoxylakis V; Hegenbarth P; Timke C; Saleh-Ebrahimi L; Debus J; Röder F; Huber PE
    Radiat Oncol; 2016 Feb; 11():17. PubMed ID: 26847089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Definitive Stereotactic Body Radiotherapy and Outcomes in Adults With Extracranial Oligometastasis.
    Poon I; Erler D; Dagan R; Redmond KJ; Foote M; Badellino S; Biswas T; Louie AV; Lee Y; Atenafu EG; Ricardi U; Sahgal A
    JAMA Netw Open; 2020 Nov; 3(11):e2026312. PubMed ID: 33196810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases.
    Frakes JM; Figura NB; Ahmed KA; Juan TH; Patel N; Latifi K; Sarangkasiri S; Strom TJ; Chinnaiyan P; Rao NG; Etame AB
    J Neurosurg; 2015 Nov; 123(5):1261-7. PubMed ID: 26140482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-Term Results of a Phase 1 Dose-Escalation Trial and Subsequent Institutional Experience of Single-Fraction Stereotactic Ablative Radiation Therapy for Liver Metastases.
    Folkert MR; Meyer JJ; Aguilera TA; Yokoo T; Sanford NN; Rule WG; Mansour J; Yopp A; Polanco P; Hannan R; Nedzi LA; Timmerman RD
    Int J Radiat Oncol Biol Phys; 2021 Apr; 109(5):1387-1395. PubMed ID: 33340601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival after surgery and stereotactic radiosurgery for patients with multiple intracranial metastases: results of a single-center retrospective study.
    Smith TR; Lall RR; Lall RR; Abecassis IJ; Arnaout OM; Marymont MH; Swanson KR; Chandler JP
    J Neurosurg; 2014 Oct; 121(4):839-45. PubMed ID: 24857242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment outcomes of breast cancer liver metastasis treated with stereotactic body radiotherapy.
    Onal C; Guler OC; Yildirim BA
    Breast; 2018 Dec; 42():150-156. PubMed ID: 30296648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.